Melanoma

>

Latest News

Lifileucel Shows Long-Term Efficacy in Melanoma
Lifileucel Shows Long-Term Efficacy in Melanoma

March 18th 2024

In patients with advanced melanoma, lifileucel showed durable efficacy and a 4-year overall survival rate of 21.9%, according to long-term findings from the phase 2 C-144-01 trial.

TILT-123/TIL Combo Appears Safe and Feasible in Metastatic Melanoma
TILT-123/TIL Combo Appears Safe and Feasible in Metastatic Melanoma

March 17th 2024

Dosing and Regimen Changes Promote Tolerability in Advanced Melanoma
Dosing and Regimen Changes Promote Tolerability in Advanced Melanoma

March 14th 2024

AHN Launches Cutting-Edge Melanoma and Skin Cancer Center
AHN Launches Cutting-Edge Melanoma and Skin Cancer Center

March 14th 2024

Lifileucel Data Encourage Expansion to Solid Tumor Setting
Lifileucel Data Encourage Expansion to Solid Tumor Setting

March 13th 2024

Video Series
Video Interviews
Podcasts

More News